Salaqua Diagnostics was formed to solve and commercialize the factor(s) responsible for a hitherto poorly understood yet extraordinarily common co-morbid feature of hospital admitted patients – a condition termed hyponatremia derived from renal salt wasting (RSW). The Company has identified the new natriuretic factor which forms the basis of a
New diagnostic test to determine hyponatremia/renal salt wasting
New therapeutic to treat hyponatremia/renal salt wasting
New diuretic which acts in an entirely different way to conventional diuretics